
Erica S Y Lin
Examiner (ID: 4581, Phone: (571)270-7911 , Office: P/2853 )
| Most Active Art Unit | 2853 |
| Art Unit(s) | 2853, 2861 |
| Total Applications | 1103 |
| Issued Applications | 882 |
| Pending Applications | 99 |
| Abandoned Applications | 155 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16541009
[patent_doc_number] => 20200407422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => A METHOD OF INTRACELLULAR DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/643964
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643964
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643964 | A METHOD OF INTRACELLULAR DELIVERY | Sep 4, 2018 | Abandoned |
Array
(
[id] => 13774887
[patent_doc_number] => 20190000982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => METHODS, SYSTEMS AND COMPOSITIONS RELATING TO CELL CONVERSION VIA PROTEIN-INDUCED IN-VIVO CELL REPROGRAMMING
[patent_app_type] => utility
[patent_app_number] => 16/120829
[patent_app_country] => US
[patent_app_date] => 2018-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16120829
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/120829 | Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming | Sep 3, 2018 | Issued |
Array
(
[id] => 14806303
[patent_doc_number] => 20190269761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => METHODS, COMPOSITIONS AND SCREENS FOR THERAPEUTICS FOR THE TREATMENT OF SYNOVIAL SARCOMA
[patent_app_type] => utility
[patent_app_number] => 16/115440
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16115440
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/115440 | METHODS, COMPOSITIONS AND SCREENS FOR THERAPEUTICS FOR THE TREATMENT OF SYNOVIAL SARCOMA | Aug 27, 2018 | Abandoned |
Array
(
[id] => 14581879
[patent_doc_number] => 20190218548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => Method for Producing N-acetylglucosamine by Co-utilizing Glucose and Xylose Based on CRISPRi
[patent_app_type] => utility
[patent_app_number] => 16/112959
[patent_app_country] => US
[patent_app_date] => 2018-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16112959
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/112959 | Method for producing N-acetylglucosamine by co-utilizing glucose and xylose based on CRISPRi | Aug 26, 2018 | Issued |
Array
(
[id] => 14043921
[patent_doc_number] => 20190078067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => HALOACID DEHALOGENASE hdl4a PROTEIN VARIANT AND METHOD OF REDUCING CONCENTRATION OF FLUORINE-CONTAINING COMPOUND IN A SAMPLE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/107635
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16107635
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/107635 | HALOACID DEHALOGENASE hdl4a PROTEIN VARIANT AND METHOD OF REDUCING CONCENTRATION OF FLUORINE-CONTAINING COMPOUND IN A SAMPLE USING THE SAME | Aug 20, 2018 | Abandoned |
Array
(
[id] => 13870873
[patent_doc_number] => 20190031777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => Compositions and Methods for Detecting, Treating and Preventing Diseases and Disorders
[patent_app_type] => utility
[patent_app_number] => 16/106338
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16106338
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/106338 | Compositions and methods for detecting, treating and preventing diseases and disorders | Aug 20, 2018 | Issued |
Array
(
[id] => 15963655
[patent_doc_number] => 20200165579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => A RECOMBINANT FLAVIN-ADENINE DINUCLEOTIDE GLUCOSE DEHYDROGENASE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/636013
[patent_app_country] => US
[patent_app_date] => 2018-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16636013
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/636013 | Recombinant flavin-adenine dinucleotide glucose dehydrogenase and uses thereof | Aug 1, 2018 | Issued |
Array
(
[id] => 13774559
[patent_doc_number] => 20190000818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases
[patent_app_type] => utility
[patent_app_number] => 16/046247
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16046247
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/046247 | Method to predict response to pharmacological chaperone treatment of diseases | Jul 25, 2018 | Issued |
Array
(
[id] => 13827179
[patent_doc_number] => 20190017074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => METHODS FOR GENOMIC INTEGRATION
[patent_app_type] => utility
[patent_app_number] => 16/044381
[patent_app_country] => US
[patent_app_date] => 2018-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16044381
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/044381 | Methods for genomic integration | Jul 23, 2018 | Issued |
Array
(
[id] => 17200475
[patent_doc_number] => 20210340570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => COMPOSITIONS AND METHODS FOR INCREASING THE EFFICIENCY OF CELL CULTURES USED FOR FOOD PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 16/630404
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630404
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630404 | Compositions and methods for increasing the efficiency of cell cultures used for food production | Jul 12, 2018 | Issued |
Array
(
[id] => 15782511
[patent_doc_number] => 10624958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => Compositions and methods for treating pathological calcification and ossification
[patent_app_type] => utility
[patent_app_number] => 16/033948
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 28
[patent_no_of_words] => 25810
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16033948
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/033948 | Compositions and methods for treating pathological calcification and ossification | Jul 11, 2018 | Issued |
Array
(
[id] => 13778079
[patent_doc_number] => 20190002578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => Targeted Protein Degradation
[patent_app_type] => utility
[patent_app_number] => 16/024999
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16024999
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/024999 | Targeted protein degradation | Jul 1, 2018 | Issued |
Array
(
[id] => 13734081
[patent_doc_number] => 20180371508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => MICROBIAL PRODUCTION OF SUCCINATE DERIVED PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 16/015101
[patent_app_country] => US
[patent_app_date] => 2018-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16015101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/015101 | Microbial production of succinate derived products | Jun 20, 2018 | Issued |
Array
(
[id] => 18733553
[patent_doc_number] => 11802276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Purification of polymerase complexes
[patent_app_type] => utility
[patent_app_number] => 15/989109
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 19805
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989109
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/989109 | Purification of polymerase complexes | May 23, 2018 | Issued |
Array
(
[id] => 17858554
[patent_doc_number] => 11439692
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-13
[patent_title] => Method of treating diseases associated with MYD88 pathways using CRISPR-GNDM system
[patent_app_type] => utility
[patent_app_number] => 16/614145
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 9646
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614145
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/614145 | Method of treating diseases associated with MYD88 pathways using CRISPR-GNDM system | May 16, 2018 | Issued |
Array
(
[id] => 16091127
[patent_doc_number] => 20200199550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => CELL COMPRISING A CHIMERIC ANTIGEN RECEPTOR (CAR)
[patent_app_type] => utility
[patent_app_number] => 16/613312
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613312
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/613312 | CELL COMPRISING A CHIMERIC ANTIGEN RECEPTOR (CAR) | May 13, 2018 | Abandoned |
Array
(
[id] => 14159197
[patent_doc_number] => 20190106701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING 3-HYDROXYISOBUTYRATE OR METHACRYLIC ACID RELATED THERETO
[patent_app_type] => utility
[patent_app_number] => 15/979313
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15979313
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/979313 | MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING 3-HYDROXYISOBUTYRATE OR METHACRYLIC ACID RELATED THERETO | May 13, 2018 | Abandoned |
Array
(
[id] => 18301091
[patent_doc_number] => 11622977
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-11
[patent_title] => Materials and methods for engineering cells and uses thereof in immuno-oncology
[patent_app_type] => utility
[patent_app_number] => 16/613057
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 103
[patent_figures_cnt] => 114
[patent_no_of_words] => 87417
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613057
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/613057 | Materials and methods for engineering cells and uses thereof in immuno-oncology | May 10, 2018 | Issued |
Array
(
[id] => 13400057
[patent_doc_number] => 20180251571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF POMPE DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/978075
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978075
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/978075 | METHODS AND COMPOSITIONS FOR TREATMENT OF POMPE DISEASE | May 10, 2018 | Abandoned |
Array
(
[id] => 14501275
[patent_doc_number] => 20190194292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => Enveloped Virus Resistant to Complement Inactivation for the Treatment of Cancer
[patent_app_type] => utility
[patent_app_number] => 16/303729
[patent_app_country] => US
[patent_app_date] => 2018-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303729
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303729 | Enveloped virus resistant to complement inactivation for the treatment of cancer | May 9, 2018 | Issued |